Director/PDMR Dealings

RNS Number : 3441T

Instem plc

17 July 2020

 

Instem plc
("Instem" or the "Company")

Director/PDMR Dealings

Instem  (AIM: INS.L), a leading provider of IT solutions to the global life sciences market,  confirms the following dealings in Ordinary Shares by certain of the Company's Directors (each of whom is a PDMR) and, where relevant, their PCAs as outlined below. These dealings are further to the Company's announcement made on 26 June 2020 regarding the proposed Placing which completed this morning:

Director/PDMR	No. of Ordinary Shares held prior to the Placing	No. of options over Ordinary Shares exercised	No. of Ordinary Shares sold in the Placing	Resulting number of Ordinary Shares	As a % of Enlarged Share Capital
David Gare and his wife (via the DG 2008 Discretionary Settlement)	578,427	-	(40,000)	538,427	2.6%
Phil Reason	685,287	187,427	(142,000)	730,714	3.6%
David Sherwin	1,180,066	-	(430,066)	750,000	3.7%

Capitalised terms used in this announcement shall, unless defined in this announcement or unless the context provides otherwise, bear the same meaning ascribed to such terms in the in the Circular and Notice of General Meeting dated 30 June 2020, a copy of which is available to view on the Company's website at https://investors.instem.com/news/articles/0620-publication-of-circular.php .

For further information, please contact:

Instem plc	[phone]
Phil Reason, CEO
Nigel Goldsmith, CFO
N+1 Singer (Nominated Adviser & Broker)	[phone]
Peter Steel Rachel Hayes
Walbrook Financial PR	[phone]
Tom Cooper	[e-mail]
Nick Rome

About Instem  

Instem is a leading provider of IT solutions & services to the life sciences market delivering compelling solutions for Study Management and Data Collection; Regulatory Solutions for Submissions and Compliance; and Informatics-based Insight Generation.

Instem solutions are in use by over 500 customers worldwide, including all the largest 25 pharmaceutical companies, enabling clients to bring life enhancing products to market faster. Instem's portfolio of software solutions increases client productivity by automating study-related processes while offering the unique ability to generate new knowledge through the extraction and harmonisation of actionable scientific information.

Instem products and services now address aspects of the entire drug development value chain, from discovery through to market launch. Management estimate that over 50% of all drugs on the market have been through some part of Instem's platform at some stage of their development.

To learn more about Instem solutions and its mission, please visit   www.instem.com .

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	David Gare and his wife (via the DG 2008 Discretionary Settlement)
2	Reason for the notification
a)	Position / status	Non-Executive Chairman
b)	Initial notification / Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Instem plc
b)	LEI	213800PILYUFNNROQX68
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument , type of instrument Identification code	Ordinary shares of 10 pence each GB00B3TQCK30
b)	Nature of the transaction	Sale of ordinary shares
c)	Price(s) and volume(s)	Price	Volume
		435 pence	40,000
d)	Aggregated information - Aggregated volume - Price	N/A - single transaction
e)	Date of the transaction	17 July 2020
f)	Place of the transaction	London Stock Exchange, AIM Market (XLON)

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Phil Reason
2	Reason for the notification
a)	Position / status	Chief Executive Officer
b)	Initial notification / Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Instem plc
b)	LEI	213800PILYUFNNROQX68
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument , type of instrument Identification code	Ordinary shares of 10 pence each GB00B3TQCK30
b)	Nature of the transaction	1.  Exercise of options over Ordinary Shares 2.  Sale of Ordinary Shares
c)	Price(s) and volume(s)	Price	Volume
		1.  175 pence 2.  435 pence	1.  187,427 2.  142,000
d)	Aggregated information - Aggregated volume - Price	n/a - the exercise of options over Ordinary Shares and the sale of Ordinary Shares each completed as single transactions
e)	Date of the transaction	17 July 2020
f)	Place of the transaction	In respect of the exercise of options over Ordinary Shares: outside a trading venue In respect of the sale of Ordinary Shares: London Stock Exchange, AIM Market (XLON)

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	David Sherwin
2	Reason for the notification
a)	Position / status	Non-Executive Director
b)	Initial notification / Amendment	Initial Notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Instem plc
b)	LEI	213800PILYUFNNROQX68
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument , type of instrument Identification code	Ordinary shares of 10 pence each GB00B3TQCK30
b)	Nature of the transaction	Sale of Ordinary Shares
c)	Price(s) and volume(s)	Price	Volume
		435 pence	430,066
d)	Aggregated information - Aggregated volume - Price	N/A - single transaction
e)	Date of the transaction	17 July 2020
f)	Place of the transaction	London Stock Exchange, AIM Market (XLON)

Name of authorised official of issuer responsible for making notification:

Nigel Goldsmith

Company Secretary to Instem plc  

 

END

 

 

DSHKKOBDFBKKQOD